ArticleJournal of hematology & oncology2016

Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia.

Pei-Jie Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.